PDIA1 inhibitor KSC-34;KSC-34;Acetamide, 2-chloro-N-[2-[[4-[methyl(4-phenylbutyl)amino]-6-(2-propyn-1-ylamino)-1,3,5-triazin-2-yl]amino]ethyl]-;KSC-34, 10 mM in DMSO;2-Chloro-N-[2-[[4-[methyl(4-phenylbutyl)amino]-6-(prop-2-ynylamino)-1,3,5-triazin-2-yl]amino]ethyl]acetamide
KSC-34 is a covalent modifier and potent active-site selective inhibitor of protein disulfide isomerase A1 (PDIA1), with an IC50 of 3.5 μM for the a active site and 104.5 μM for the a′ active site, demonstrating 30-fold selectivity for the a′ domain; it exhibits selectivity for PDIA1 over other PDI family members and cellular cysteine-containing proteins, and is used to study PDIA1 function through covalent modification of Cys53 in the PDIA1 active site.